These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4993911)

  • 1. [Low-green environment for the overcoming of granulocytopenic stages in leukemia therapy].
    Wendt F; Grüning B; Lenz B; Brittinger G; Linzenmeier G
    Verh Dtsch Ges Inn Med; 1969; 75():916-20. PubMed ID: 4993911
    [No Abstract]   [Full Text] [Related]  

  • 2. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.
    Levine AS; Siegel SE; Schreiber AD; Hauser J; Preisler H; Goldstein IM; Seidler F; Simon R; Perry S; Bennett JE; Henderson ES
    N Engl J Med; 1973 Mar; 288(10):477-83. PubMed ID: 4630706
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of infection in patients with agranulocytosis through isolation and whole-body decontamination].
    Fopp M; Gasser A; Eigenmann B; Jungi WF; Meuret G; Senn HJ
    Schweiz Med Wochenschr; 1975 Aug; 105(35):1123-5. PubMed ID: 808849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infection prophylaxis in granulocytopenia by clinical gnotobiotics].
    Günther I; Bohnenstengel C; Brijmohan-Günther R; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):715-20. PubMed ID: 6172339
    [No Abstract]   [Full Text] [Related]  

  • 5. Protected environment units for the cancer patient.
    Bodey GP; Watson P; Cooper C; Freireich EJ
    CA Cancer J Clin; 1971; 21(4):215-9. PubMed ID: 4998235
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of infection with protected environment and prophylactic antibiotics in the therapy of acute leukemia.
    Nagao T; Watanabe K; Nozaki H; Komatsuda M; Arimori S
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):78-85. PubMed ID: 6797215
    [No Abstract]   [Full Text] [Related]  

  • 7. Protected environment units in the treatment of acute leukemia.
    Preisler HD; Bjornsson S
    Semin Oncol; 1975 Dec; 2(4):369-77. PubMed ID: 824738
    [No Abstract]   [Full Text] [Related]  

  • 8. Perspectives and controversies in the prevention of infection in granulocytopenic patients.
    Klastersky J
    Eur J Clin Microbiol; 1983 Apr; 2(2):91-4. PubMed ID: 6861738
    [No Abstract]   [Full Text] [Related]  

  • 9. [Infection in the granulocytopenic patient].
    Cajozzo A
    Haematologica; 1989 Oct; 74(5 Suppl):275-7. PubMed ID: 2512213
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient isolation units for cancer patients treated with chemical immunosuppressive agents.
    Bodey GP
    Transplant Proc; 1973 Sep; 5(3):1279-84. PubMed ID: 4199579
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of acute leukemia: current perspectives and relative curability].
    Cauchie C; Kenis Y; Maurus R; Naets JP; Stryckmans P; Tagnon PH
    Brux Med; 1970 Mar; 50(3):175-84. PubMed ID: 5267257
    [No Abstract]   [Full Text] [Related]  

  • 12. Protected environment--prophylactic antibiotic programmes; clinical studies.
    Levine AS
    Clin Haematol; 1976 Jun; 5(2):409-24. PubMed ID: 939058
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of infection in patients with acute leukemia.
    Wade JC
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):293-315. PubMed ID: 8449863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains.
    Klastersky J; Debusscher L; Weerts D; Daneau D
    Pathol Biol (Paris); 1974 Jan; 22(1):5-12. PubMed ID: 4360753
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial therapy in the myelo- and immuno-compromised patient.
    van den Broek PJ; van der Meer JW
    Neth J Med; 1979; 22(4):118-22. PubMed ID: 113688
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of infectious complications in patients with myelosuppression by means of isolation and oral administration of non-absorptive antibiotics (evaluation of clinical effectiveness)].
    Baranov AE; Nadezhina NM
    Ter Arkh; 1978; 50(7):38-45. PubMed ID: 213855
    [No Abstract]   [Full Text] [Related]  

  • 17. Empiric antibiotic therapy for granulocytopenic patients.
    Schimpff SC
    Bull N Y Acad Med; 1982 Nov; 58(8):750-6. PubMed ID: 6963185
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of infections in granulocytopenic and immunocompromised cancer patients.
    Klastersky J
    Kansenshogaku Zasshi; 1988 Mar; 62 Suppl():25-34. PubMed ID: 3138351
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proceedings: Experiences with isolation of leukemic patients].
    Schäden J
    Schweiz Med Wochenschr; 1975 Dec; 105(51):1792-4. PubMed ID: 1215983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary studies of the effectiveness of a patient isolation unit and of prophylactic antibiotics in therapy of acute leukemia.
    Klastersky J; Cappel R; Debusscher L; Lachapelle F
    Acta Clin Belg; 1971; 26(4):191-200. PubMed ID: 5004992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.